LeMaitre Vascular, Inc.
Cash Flow Statement
| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $15.0M | $17.1M | $15.7M | $15.6M | $17.4M | $13.8M | $11.0M | $11.2M |
| Depreciation & Amortization | $2.9M | $2.7M | $2.6M | $2.6M | $2.6M | $2.6M | $2.6M | $2.4M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | $1.4M | $1.4M | $1.4M | $1.3M | $1.4M | $1.4M | $1.4M | $1.4M |
| Stock-Based Compensation | $2.0M | $1.9M | $2.1M | $2.1M | $1.7M | $1.9M | $2.0M | $1.7M |
| Net Cash from Operating Activities | $22.0M | $16.0M | $15.1M | $23.2M | $28.8M | $20.3M | $9.0M | $15.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $2.3M | $2.3M | $2.8M | $1.8M | $2.3M | $1.3M | $1.4M | $2.0M |
| Business Acquisitions | $36.0K | $113.0K | $45.0K | $1.8M | $0 | $51.0K | $44.0K | $0 |
| Net Cash from Investing Activities | $-16.2M | $-11.1M | $-13.1M | $-16.8M | $-27.4M | $-16.3M | $-4.3M | $-173.9M |
| Financing Activities | ||||||||
| Dividends Paid | $5.7M | $5.7M | $5.7M | $4.5M | $4.5M | $4.5M | $4.5M | $3.6M |
| Stock Repurchases | $0 | $17.0K | $460.0K | $1.2M | $0 | $4.0K | $601.0K | $1.4M |
| Net Cash from Financing Activities | $-5.0M | $-5.1M | $-3.2M | $-3.6M | $-3.0M | $-2.8M | $-5.2M | $164.1M |
| Net Change in Cash | $868.0K | $-226.0K | $-1.4M | $2.8M | $-1.7M | $1.8M | $-270.0K | $4.6M |
| Free Cash Flow | $19.7M | $13.7M | $12.3M | $21.4M | $26.5M | $18.9M | $7.7M | $13.1M |